What clinical trials have been done for Ravicti (glycerol phenylbutyrate) MTC8?
“MTC8” is not a widely used clinical-trial identifier term for Ravicti in standard public regulatory or clinical-trial listings. If you mean a specific study name (for example, a protocol code, sponsor-internal study label, or an NCT trial number), sharing the full label (or the NCT number) would let me match it to the exact Ravicti trial records.
Where to find the official Ravicti trial records (and how to verify “MTC8”)
The most reliable places to confirm trial design, inclusion criteria, endpoints, and published results for Ravicti are:
- ClinicalTrials.gov (by drug name and any study code you have)
- Sponsor and regulatory documents (FDA labels and review documents)
- Peer-reviewed publications that cite the specific protocol/study identifier
If you provide the study’s exact identifier (preferred: NCT number; also acceptable: the full protocol title/code), I can summarize the trial’s:
- patient population (e.g., urea cycle disorders, age group)
- dosing regimen and treatment duration
- primary/secondary endpoints (ammonia control, rescue rates, etc.)
- key safety findings
Why Ravicti trials often focus on urea cycle disorder outcomes
Ravicti is used in urea cycle disorders (where patients need long-term ammonia-lowering therapy). Clinical trial programs for these conditions typically track outcomes like ammonia levels and biochemical control, along with safety and tolerability across repeated dosing.
Can you share the exact “MTC8” label you saw?
To pinpoint the right trial, paste one of the following:
- the NCT number
- the exact text around “MTC8” (for example, “Study MTC8-###”)
- a link or screenshot text from the source you’re using
Sources: None provided (no specific trial identifier or external documents were included in your message).